277 related articles for article (PubMed ID: 22913825)
1. [Modulation of leukotriene pathway - potential targets].
Peter H; Lýdia B
Ceska Slov Farm; 2012 Jun; 61(3):101-6. PubMed ID: 22913825
[TBL] [Abstract][Full Text] [Related]
2. [Inhibitors of 5-lipoxygenase].
Gápovský M; Remko M
Ceska Slov Farm; 2002 Mar; 51(2):55-62. PubMed ID: 11928277
[TBL] [Abstract][Full Text] [Related]
3. Leukotrienes: lipid bioeffectors of inflammatory reactions.
Sala A; Zarini S; Bolla M
Biochemistry (Mosc); 1998 Jan; 63(1):84-92. PubMed ID: 9526099
[TBL] [Abstract][Full Text] [Related]
4. The role of leukotrienes in the pathophysiology of inflammatory disorders: is there a case for revisiting leukotrienes as therapeutic targets?
Sharma JN; Mohammed LA
Inflammopharmacology; 2006 Mar; 14(1-2):10-6. PubMed ID: 16835707
[TBL] [Abstract][Full Text] [Related]
5. Immunopharmacological role of the leukotriene receptor antagonists and inhibitors of leukotrienes generating enzymes in multiple sclerosis.
Mirshafiey A; Jadidi-Niaragh F
Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):219-27. PubMed ID: 20298145
[TBL] [Abstract][Full Text] [Related]
6. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M
Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery approaches targeting 5-lipoxygenase-activating protein (FLAP) for inhibition of cellular leukotriene biosynthesis.
Gür ZT; Çalışkan B; Banoglu E
Eur J Med Chem; 2018 Jun; 153():34-48. PubMed ID: 28784429
[TBL] [Abstract][Full Text] [Related]
8. Advances in eicosanoid research, novel therapeutic implications.
Haeggström JZ; Rinaldo-Matthis A; Wheelock CE; Wetterholm A
Biochem Biophys Res Commun; 2010 May; 396(1):135-9. PubMed ID: 20494126
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene inflammatory mediators meet their match.
Funk CD
Sci Transl Med; 2011 Jan; 3(66):66ps3. PubMed ID: 21248314
[TBL] [Abstract][Full Text] [Related]
10. Cell biology of the 5-lipoxygenase pathway.
Peters-Golden M
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 2):S227-31; discussion S231-2, S247-8. PubMed ID: 9647604
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of the 5-lipoxygenase pathway in atherosclerosis.
Bäck M
Curr Pharm Des; 2009; 15(27):3116-32. PubMed ID: 19754386
[TBL] [Abstract][Full Text] [Related]
12. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
Parker AR; Ayars AG; Altman MC; Henderson WR
Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
[TBL] [Abstract][Full Text] [Related]
13. Roles of cysteinyl leukotrienes and their receptors in immune cell-related functions.
Kanaoka Y; Austen KF
Adv Immunol; 2019; 142():65-84. PubMed ID: 31296303
[TBL] [Abstract][Full Text] [Related]
14. Targeting cysteinyl leukotrienes in patients with rhinitis, sinusitis and paranasal polyps.
Parnes SM
Am J Respir Med; 2002; 1(6):403-8. PubMed ID: 14720027
[TBL] [Abstract][Full Text] [Related]
15. Expression of enzymes and receptors of leukotriene pathway genes in equine endometrium during the estrous cycle and early pregnancy.
Guzeloglu A; Atli MO; Kurar E; Kayis SA; Handler J; Semacan A; Aslan S
Theriogenology; 2013 Jul; 80(2):145-52. PubMed ID: 23623165
[TBL] [Abstract][Full Text] [Related]
16. 5-Lipoxygenase: a target for antiinflammatory drugs revisited.
Steinhilber D
Curr Med Chem; 1999 Jan; 6(1):71-85. PubMed ID: 9873115
[TBL] [Abstract][Full Text] [Related]
17. Leukotrienes in respiratory disease.
McMillan RM
Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandins and leukotrienes: advances in eicosanoid biology.
Funk CD
Science; 2001 Nov; 294(5548):1871-5. PubMed ID: 11729303
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of leukotriene receptor antagonists and 5-lipoxygenase inhibitors in the management of asthma.
Drazen JM
Pharmacotherapy; 1997; 17(1 Pt 2):22S-30S. PubMed ID: 9017785
[TBL] [Abstract][Full Text] [Related]
20. [The significance of leukotrienes in pathophysiology of bronchial asthma--therapy perspectives].
Wojnowski P; Patkowski J
Postepy Hig Med Dosw; 1997; 51(5):499-514. PubMed ID: 9489451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
